Literature DB >> 31051044

Nodular Leptomeningeal Disease After Surgery for a Brain Metastasis - Should We Be Concerned?

Michael A Vogelbaum1, H Michael Yu2.   

Abstract

Entities:  

Year:  2019        PMID: 31051044      PMCID: PMC6682200          DOI: 10.1093/neuonc/noz081

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN: 1522-8517            Impact factor:   12.300


× No keyword cloud information.
  11 in total

1.  Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial.

Authors:  Hidefumi Aoyama; Hiroki Shirato; Masao Tago; Keiichi Nakagawa; Tatsuya Toyoda; Kazuo Hatano; Masahiro Kenjyo; Natsuo Oya; Saeko Hirota; Hiroki Shioura; Etsuo Kunieda; Taisuke Inomata; Kazushige Hayakawa; Norio Katoh; Gen Kobashi
Journal:  JAMA       Date:  2006-06-07       Impact factor: 56.272

2.  A randomized trial of surgery in the treatment of single metastases to the brain.

Authors:  R A Patchell; P A Tibbs; J W Walsh; R J Dempsey; Y Maruyama; R J Kryscio; W R Markesbery; J S Macdonald; B Young
Journal:  N Engl J Med       Date:  1990-02-22       Impact factor: 91.245

3.  A multi-institutional analysis of presentation and outcomes for leptomeningeal disease recurrence after surgical resection and radiosurgery for brain metastases.

Authors:  Roshan S Prabhu; Brandon E Turner; Anthony L Asher; Samuel R Marcrom; John B Fiveash; Paul M Foreman; Robert H Press; Kirtesh R Patel; Walter J Curran; William G Breen; Paul D Brown; Krishan R Jethwa; Inga S Grills; Jessica D Arden; Lauren M Foster; Matthew A Manning; Joseph D Stern; Scott G Soltys; Stuart H Burri
Journal:  Neuro Oncol       Date:  2019-08-05       Impact factor: 12.300

4.  Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial.

Authors:  Paul D Brown; Karla V Ballman; Jane H Cerhan; S Keith Anderson; Xiomara W Carrero; Anthony C Whitton; Jeffrey Greenspoon; Ian F Parney; Nadia N I Laack; Jonathan B Ashman; Jean-Paul Bahary; Costas G Hadjipanayis; James J Urbanic; Fred G Barker; Elana Farace; Deepak Khuntia; Caterina Giannini; Jan C Buckner; Evanthia Galanis; David Roberge
Journal:  Lancet Oncol       Date:  2017-07-04       Impact factor: 41.316

5.  Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain Metastases: A Randomized Clinical Trial.

Authors:  Paul D Brown; Kurt Jaeckle; Karla V Ballman; Elana Farace; Jane H Cerhan; S Keith Anderson; Xiomara W Carrero; Fred G Barker; Richard Deming; Stuart H Burri; Cynthia Ménard; Caroline Chung; Volker W Stieber; Bruce E Pollock; Evanthia Galanis; Jan C Buckner; Anthony L Asher
Journal:  JAMA       Date:  2016-07-26       Impact factor: 56.272

6.  Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial.

Authors:  David W Andrews; Charles B Scott; Paul W Sperduto; Adam E Flanders; Laurie E Gaspar; Michael C Schell; Maria Werner-Wasik; William Demas; Janice Ryu; Jean-Paul Bahary; Luis Souhami; Marvin Rotman; Minesh P Mehta; Walter J Curran
Journal:  Lancet       Date:  2004-05-22       Impact factor: 79.321

7.  Comparing Preoperative With Postoperative Stereotactic Radiosurgery for Resectable Brain Metastases: A Multi-institutional Analysis.

Authors:  Kirtesh R Patel; Stuart H Burri; Anthony L Asher; Ian R Crocker; Robert W Fraser; Chao Zhang; Zhengjia Chen; Shravan Kandula; Jim Zhong; Robert H Press; Jeffery J Olson; Nelson M Oyesiku; Scott D Wait; Walter J Curran; Hui-Kuo G Shu; Roshan S Prabhu
Journal:  Neurosurgery       Date:  2016-08       Impact factor: 4.654

8.  Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial.

Authors:  Eric L Chang; Jeffrey S Wefel; Kenneth R Hess; Pamela K Allen; Frederick F Lang; David G Kornguth; Rebecca B Arbuckle; J Michael Swint; Almon S Shiu; Moshe H Maor; Christina A Meyers
Journal:  Lancet Oncol       Date:  2009-10-02       Impact factor: 41.316

9.  Association of Neurosurgical Resection With Development of Pachymeningeal Seeding in Patients With Brain Metastases.

Authors:  Daniel N Cagney; Nayan Lamba; Sumi Sinha; Paul J Catalano; Wenya Linda Bi; Brian M Alexander; Ayal A Aizer
Journal:  JAMA Oncol       Date:  2019-05-01       Impact factor: 31.777

10.  Post-operative stereotactic radiosurgery versus observation for completely resected brain metastases: a single-centre, randomised, controlled, phase 3 trial.

Authors:  Anita Mahajan; Salmaan Ahmed; Mary Frances McAleer; Jeffrey S Weinberg; Jing Li; Paul Brown; Stephen Settle; Sujit S Prabhu; Frederick F Lang; Nicholas Levine; Susan McGovern; Erik Sulman; Ian E McCutcheon; Syed Azeem; Daniel Cahill; Claudio Tatsui; Amy B Heimberger; Sherise Ferguson; Amol Ghia; Franco Demonte; Shaan Raza; Nandita Guha-Thakurta; James Yang; Raymond Sawaya; Kenneth R Hess; Ganesh Rao
Journal:  Lancet Oncol       Date:  2017-07-04       Impact factor: 41.316

View more
  2 in total

1.  Surgical and anatomic factors predict development of leptomeningeal disease in patients with melanoma brain metastases.

Authors:  Stephen R Lowe; Christopher P Wang; Amanda Brisco; Junmin Whiting; John Arrington; Kamran Ahmed; Michael Yu; Timothy Robinson; Daniel Oliver; Arnold Etame; Nam Tran; Andre Beer Furlan; Solmaz Sahebjam; Sepideh Mokhtari; Yolanda Piña; Robert Macaulay; Peter Forsyth; Michael A Vogelbaum; James K C Liu
Journal:  Neuro Oncol       Date:  2022-08-01       Impact factor: 13.029

2.  Evaluation of neurapheresis therapy in vitro: a novel approach for the treatment of leptomeningeal metastases.

Authors:  Tiffany Ejikeme; George C de Castro; Katelyn Ripple; Yutong Chen; Charles Giamberardino; Andrew Bartuska; Gordon Smilnak; Choiselle Marius; Jane-Valeriane Boua; Pakawat Chongsathidkiet; Sarah Hodges; Promila Pagadala; Laura Zitella Verbick; Aaron R McCabe; Shivanand P Lad
Journal:  Neurooncol Adv       Date:  2020-04-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.